Skip to main content


Table 5 Incremental cost-effectiveness ratio (ICER) for clinicians' adherence versus non adherence to clinical practice guidelines (CPGs)

From: Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions

  Mean cost per patient(€, 2009) Mean Incremental Cost[[]](€, 2009) Mean effectiveness per patient(Relapse-free survival, years) Mean Incremental Effectiveness[[]](Relapse-free survival, years) ICER(€ per relapse-free year gained)[[]]
Overall management CPG (+) 23,571 - 2.46 -  
Overall management CPG (-) 27,313 3,742 2.16 -0.30 Dominated